Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 69 Carcinoma, Non-Small-Cell Lung 62 Stomach Neoplasms 32 Prostatic Neoplasms 21 Nasopharyngeal Carcinoma 20 Lung Neoplasms 20 Squamous Cell Carcinoma of Head and Neck 11 Esophageal Neoplasms 11 Neoplasm Metastasis 8 Head and Neck Neoplasms 7 Inflammatory Breast Neoplasms 6 Pancreatic Neoplasms 5 Neoplasms 5 HER2-positive Breast Cancer 5 Adenocarcinoma 5 Triple Negative Breast Neoplasms 4 Ovarian Neoplasms 4 NSCLC 4 Carcinoma, Squamous Cell 4 Sarcoma 3 Nasopharyngeal Neoplasms 3 Hypopharyngeal Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Carcinoma, Ovarian Epithelial 3 Breast Diseases 3 Adenocarcinoma of Lung 3 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Tongue Neoplasms 2 Squamous Cell Lung Cancer 2

Interventions

Gonadotropin-Releasing Hormone 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Salivary Gland Adenoma, Pleomorphic × Docetaxel × Clear all

NCT00764166 2008-10-01

RisingPSA

Assistance Publique - Hôpitaux de Paris

Phase 3 Unknown

Salivary Gland Adenoma, Pleomorphic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡